Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cornea | 18 | 2019 | 69 | 1.410 |
Why?
|
| Orbital Diseases | 2 | 2019 | 21 | 0.740 |
Why?
|
| Ecchymosis | 1 | 2019 | 2 | 0.690 |
Why?
|
| Eye Hemorrhage | 1 | 2019 | 2 | 0.690 |
Why?
|
| Cavernous Sinus | 1 | 2019 | 15 | 0.690 |
Why?
|
| Conjunctival Diseases | 1 | 2019 | 7 | 0.690 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2019 | 32 | 0.670 |
Why?
|
| Keratitis | 9 | 2019 | 22 | 0.570 |
Why?
|
| Corneal Diseases | 7 | 2021 | 32 | 0.510 |
Why?
|
| Visual Acuity | 9 | 2021 | 194 | 0.490 |
Why?
|
| Keratoplasty, Penetrating | 7 | 2011 | 14 | 0.490 |
Why?
|
| Acanthamoeba Keratitis | 3 | 2021 | 8 | 0.470 |
Why?
|
| Incontinentia Pigmenti | 1 | 2009 | 2 | 0.360 |
Why?
|
| Eye Infections, Bacterial | 5 | 2019 | 14 | 0.360 |
Why?
|
| Photorefractive Keratectomy | 2 | 2000 | 4 | 0.340 |
Why?
|
| Corneal Stroma | 3 | 2021 | 12 | 0.320 |
Why?
|
| Conjunctiva | 2 | 2018 | 19 | 0.310 |
Why?
|
| Pseudomonas Infections | 6 | 1995 | 95 | 0.290 |
Why?
|
| Keratoconus | 4 | 2021 | 9 | 0.260 |
Why?
|
| Acanthamoeba | 2 | 2021 | 17 | 0.240 |
Why?
|
| Ciprofloxacin | 5 | 1995 | 29 | 0.240 |
Why?
|
| Limbus Corneae | 1 | 2003 | 1 | 0.230 |
Why?
|
| Phosphorylcholine | 2 | 2021 | 28 | 0.230 |
Why?
|
| Ophthalmic Solutions | 4 | 2018 | 16 | 0.220 |
Why?
|
| Wound Healing | 2 | 1996 | 344 | 0.220 |
Why?
|
| Collagen | 6 | 1991 | 269 | 0.210 |
Why?
|
| Debridement | 2 | 2000 | 56 | 0.200 |
Why?
|
| Contact Lenses, Extended-Wear | 1 | 2000 | 2 | 0.200 |
Why?
|
| Corneal Ulcer | 1 | 2000 | 6 | 0.190 |
Why?
|
| Punctures | 1 | 2000 | 29 | 0.190 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2000 | 24 | 0.190 |
Why?
|
| Administration, Topical | 10 | 2005 | 95 | 0.190 |
Why?
|
| Stem Cells | 1 | 2003 | 351 | 0.190 |
Why?
|
| Anterior Chamber | 4 | 1990 | 9 | 0.190 |
Why?
|
| Eye Infections, Parasitic | 1 | 2019 | 4 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 503 | 0.180 |
Why?
|
| Rabbits | 15 | 1996 | 636 | 0.180 |
Why?
|
| Micrococcaceae | 1 | 2019 | 3 | 0.180 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2019 | 47 | 0.170 |
Why?
|
| Epithelial Cells | 1 | 2003 | 669 | 0.170 |
Why?
|
| Keratoconjunctivitis | 1 | 2018 | 5 | 0.170 |
Why?
|
| Orbit | 1 | 2019 | 37 | 0.170 |
Why?
|
| Pseudolymphoma | 1 | 2018 | 9 | 0.170 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2018 | 10 | 0.160 |
Why?
|
| Prednisolone | 3 | 2018 | 41 | 0.150 |
Why?
|
| Rhinosporidiosis | 1 | 1997 | 1 | 0.150 |
Why?
|
| Descemet Stripping Endothelial Keratoplasty | 2 | 2021 | 19 | 0.150 |
Why?
|
| Biomarkers | 1 | 2003 | 1718 | 0.140 |
Why?
|
| Humans | 38 | 2021 | 86645 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2003 | 1196 | 0.140 |
Why?
|
| Embolization, Therapeutic | 1 | 2019 | 238 | 0.140 |
Why?
|
| Middle Aged | 14 | 2019 | 25028 | 0.140 |
Why?
|
| Lenses, Intraocular | 5 | 1986 | 12 | 0.130 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 218 | 0.130 |
Why?
|
| Female | 22 | 2019 | 44534 | 0.130 |
Why?
|
| Corneal Injuries | 2 | 1994 | 10 | 0.130 |
Why?
|
| Aqueous Humor | 4 | 1990 | 23 | 0.130 |
Why?
|
| Giant Cell Arteritis | 1 | 2014 | 5 | 0.130 |
Why?
|
| Child | 7 | 2009 | 6928 | 0.130 |
Why?
|
| Retinal Artery Occlusion | 1 | 2014 | 12 | 0.120 |
Why?
|
| Blindness | 1 | 2014 | 41 | 0.120 |
Why?
|
| Neurons | 1 | 2003 | 1546 | 0.120 |
Why?
|
| Biopsy | 3 | 2018 | 1163 | 0.120 |
Why?
|
| Fluoresceins | 2 | 1991 | 43 | 0.120 |
Why?
|
| Cyclosporins | 2 | 1990 | 59 | 0.120 |
Why?
|
| Corneal Transplantation | 2 | 1991 | 9 | 0.120 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1994 | 152 | 0.110 |
Why?
|
| Glucocorticoids | 4 | 2018 | 352 | 0.110 |
Why?
|
| Norfloxacin | 2 | 1991 | 5 | 0.100 |
Why?
|
| Endothelium, Corneal | 1 | 2011 | 19 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 2 | 2018 | 303 | 0.100 |
Why?
|
| Contact Lenses | 4 | 1990 | 7 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 4 | 2019 | 746 | 0.090 |
Why?
|
| Epithelium, Corneal | 2 | 2000 | 12 | 0.090 |
Why?
|
| Scleritis | 1 | 2009 | 5 | 0.090 |
Why?
|
| Lasers, Excimer | 2 | 2000 | 5 | 0.080 |
Why?
|
| Tobramycin | 5 | 1995 | 10 | 0.080 |
Why?
|
| Pseudomonas aeruginosa | 6 | 1995 | 194 | 0.080 |
Why?
|
| Tomography, Optical Coherence | 2 | 2021 | 130 | 0.080 |
Why?
|
| Brain | 1 | 2019 | 2216 | 0.080 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2008 | 5 | 0.080 |
Why?
|
| Graft Rejection | 2 | 2011 | 1065 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 1565 | 0.080 |
Why?
|
| Random Allocation | 6 | 1994 | 332 | 0.080 |
Why?
|
| Orbital Neoplasms | 1 | 1987 | 17 | 0.080 |
Why?
|
| Fibroma | 1 | 1987 | 33 | 0.070 |
Why?
|
| Adult | 11 | 2021 | 25648 | 0.070 |
Why?
|
| Astigmatism | 6 | 1998 | 10 | 0.070 |
Why?
|
| Abscess | 1 | 1987 | 91 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3362 | 0.070 |
Why?
|
| Biological Dressings | 3 | 1990 | 5 | 0.070 |
Why?
|
| Colony Count, Microbial | 5 | 1995 | 46 | 0.070 |
Why?
|
| Male | 15 | 2021 | 40967 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 526 | 0.070 |
Why?
|
| Skin | 1 | 2009 | 554 | 0.070 |
Why?
|
| Family | 1 | 2008 | 311 | 0.070 |
Why?
|
| Nocardia asteroides | 1 | 2005 | 2 | 0.070 |
Why?
|
| Antiprotozoal Agents | 2 | 2019 | 33 | 0.070 |
Why?
|
| Keratomileusis, Laser In Situ | 1 | 2005 | 2 | 0.070 |
Why?
|
| Nocardia Infections | 1 | 2005 | 5 | 0.070 |
Why?
|
| Postoperative Complications | 5 | 2011 | 2207 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2003 | 3613 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 6 | 1996 | 135 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2019 | 684 | 0.070 |
Why?
|
| Infant | 2 | 2003 | 3047 | 0.070 |
Why?
|
| Eye Neoplasms | 1 | 1985 | 27 | 0.070 |
Why?
|
| Drug Therapy, Combination | 4 | 2010 | 894 | 0.060 |
Why?
|
| Sinusitis | 1 | 1987 | 210 | 0.060 |
Why?
|
| Incidence | 2 | 2000 | 1577 | 0.060 |
Why?
|
| Pharmaceutical Vehicles | 3 | 1994 | 10 | 0.060 |
Why?
|
| Adolescent | 4 | 2010 | 8982 | 0.060 |
Why?
|
| Nestin | 1 | 2003 | 18 | 0.060 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2003 | 25 | 0.060 |
Why?
|
| Ectoderm | 1 | 2003 | 29 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 1985 | 217 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 1 | 2003 | 35 | 0.060 |
Why?
|
| Corneal Opacity | 2 | 2001 | 2 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2003 | 157 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2003 | 401 | 0.050 |
Why?
|
| Proteins | 1 | 2008 | 777 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 1 | 2003 | 396 | 0.050 |
Why?
|
| Recurrence | 2 | 2005 | 1139 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2003 | 254 | 0.050 |
Why?
|
| Amblyopia | 1 | 2001 | 7 | 0.050 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2001 | 8 | 0.050 |
Why?
|
| Animals | 15 | 1996 | 26582 | 0.050 |
Why?
|
| Corneal Edema | 1 | 2021 | 6 | 0.050 |
Why?
|
| Prednisone | 2 | 2014 | 258 | 0.050 |
Why?
|
| Corneal Topography | 2 | 2017 | 8 | 0.050 |
Why?
|
| Rupture, Spontaneous | 1 | 2021 | 43 | 0.050 |
Why?
|
| Aged | 6 | 2011 | 18415 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 279 | 0.050 |
Why?
|
| Ointments | 1 | 2000 | 12 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 6509 | 0.050 |
Why?
|
| Melanoma | 1 | 1985 | 459 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2003 | 429 | 0.050 |
Why?
|
| Slit Lamp Microscopy | 1 | 2019 | 5 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 1994 | 912 | 0.050 |
Why?
|
| DNA, Protozoan | 1 | 2019 | 16 | 0.050 |
Why?
|
| Fluorescein Angiography | 2 | 2014 | 96 | 0.050 |
Why?
|
| Keratitis, Dendritic | 2 | 1990 | 13 | 0.050 |
Why?
|
| Equipment Design | 1 | 2000 | 406 | 0.040 |
Why?
|
| Suture Techniques | 2 | 1990 | 135 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 826 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 268 | 0.040 |
Why?
|
| Benzalkonium Compounds | 1 | 2018 | 2 | 0.040 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2018 | 10 | 0.040 |
Why?
|
| Loteprednol Etabonate | 1 | 2018 | 2 | 0.040 |
Why?
|
| Administration, Ophthalmic | 1 | 2018 | 9 | 0.040 |
Why?
|
| Antigens, CD20 | 1 | 2018 | 36 | 0.040 |
Why?
|
| Simplexvirus | 2 | 1990 | 151 | 0.040 |
Why?
|
| Anti-Allergic Agents | 1 | 2018 | 39 | 0.040 |
Why?
|
| Anesthetics | 1 | 2018 | 48 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2003 | 2818 | 0.040 |
Why?
|
| Glaucoma | 2 | 2011 | 30 | 0.040 |
Why?
|
| Rhinosporidium | 1 | 1997 | 1 | 0.040 |
Why?
|
| Epithelium | 2 | 1996 | 319 | 0.040 |
Why?
|
| New York | 1 | 1997 | 69 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 1208 | 0.040 |
Why?
|
| Optic Nerve | 3 | 1985 | 35 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 243 | 0.040 |
Why?
|
| Iontophoresis | 3 | 1990 | 9 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2003 | 1565 | 0.030 |
Why?
|
| Cranial Nerve Neoplasms | 2 | 1985 | 12 | 0.030 |
Why?
|
| Blood Sedimentation | 1 | 2014 | 13 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2018 | 971 | 0.030 |
Why?
|
| Temporal Arteries | 1 | 2014 | 9 | 0.030 |
Why?
|
| Lens, Crystalline | 2 | 1986 | 69 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2014 | 40 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 2014 | 66 | 0.030 |
Why?
|
| Fluorophotometry | 2 | 1991 | 3 | 0.030 |
Why?
|
| Fluorescein | 2 | 1991 | 16 | 0.030 |
Why?
|
| Carotid Artery, Internal | 1 | 2014 | 69 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 521 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 429 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 190 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 724 | 0.030 |
Why?
|
| Carotid Stenosis | 1 | 2014 | 112 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2011 | 8491 | 0.030 |
Why?
|
| Myopia | 2 | 1990 | 10 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1985 | 427 | 0.030 |
Why?
|
| Lacrimal Duct Obstruction | 1 | 1991 | 3 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 1990 | 1204 | 0.030 |
Why?
|
| Time Factors | 2 | 1994 | 5210 | 0.030 |
Why?
|
| Graft vs Host Reaction | 1 | 1991 | 15 | 0.020 |
Why?
|
| Connective Tissue | 1 | 1991 | 23 | 0.020 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2011 | 11 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1991 | 121 | 0.020 |
Why?
|
| Plant Oils | 1 | 1990 | 9 | 0.020 |
Why?
|
| Aminoglycosides | 1 | 1990 | 32 | 0.020 |
Why?
|
| Olive Oil | 1 | 1990 | 8 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1990 | 155 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 285 | 0.020 |
Why?
|
| Quinolones | 1 | 1990 | 60 | 0.020 |
Why?
|
| Aphakia | 1 | 1990 | 10 | 0.020 |
Why?
|
| Virus Activation | 1 | 1990 | 41 | 0.020 |
Why?
|
| Bandages | 1 | 1990 | 41 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 2011 | 90 | 0.020 |
Why?
|
| Timolol | 1 | 1989 | 2 | 0.020 |
Why?
|
| Trifluridine | 1 | 1989 | 6 | 0.020 |
Why?
|
| Thymidine | 1 | 1989 | 59 | 0.020 |
Why?
|
| Iris Diseases | 2 | 1986 | 6 | 0.020 |
Why?
|
| Ophthalmology | 1 | 1989 | 39 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2009 | 59 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 1995 | 2232 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1990 | 221 | 0.020 |
Why?
|
| Reoperation | 1 | 2011 | 597 | 0.020 |
Why?
|
| Dimethylallyltranstransferase | 1 | 2008 | 1 | 0.020 |
Why?
|
| Eye Diseases | 2 | 1985 | 53 | 0.020 |
Why?
|
| Ciliary Body | 2 | 1985 | 7 | 0.020 |
Why?
|
| Iris | 2 | 1985 | 5 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2008 | 129 | 0.020 |
Why?
|
| Point Mutation | 1 | 2008 | 246 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 339 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 2 | 1991 | 353 | 0.020 |
Why?
|
| Detergents | 1 | 1986 | 34 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 3 | 1990 | 72 | 0.020 |
Why?
|
| Ultrasonics | 1 | 1986 | 38 | 0.020 |
Why?
|
| Surface-Active Agents | 1 | 1986 | 59 | 0.020 |
Why?
|
| Imipenem | 1 | 2005 | 2 | 0.020 |
Why?
|
| Aza Compounds | 1 | 2005 | 8 | 0.020 |
Why?
|
| Pedigree | 1 | 2008 | 966 | 0.020 |
Why?
|
| Fluoroquinolones | 1 | 2005 | 22 | 0.020 |
Why?
|
| Lasers | 1 | 1986 | 106 | 0.020 |
Why?
|
| Eye Injuries | 1 | 1985 | 15 | 0.020 |
Why?
|
| Choroid Neoplasms | 1 | 1985 | 6 | 0.020 |
Why?
|
| Optic Disk | 1 | 1985 | 13 | 0.020 |
Why?
|
| Lens Capsule, Crystalline | 1 | 1985 | 11 | 0.020 |
Why?
|
| Necrosis | 1 | 2005 | 204 | 0.020 |
Why?
|
| Optic Nerve Diseases | 1 | 1985 | 18 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 3 | 1990 | 274 | 0.020 |
Why?
|
| Quinolines | 1 | 2005 | 95 | 0.020 |
Why?
|
| Hamartoma | 1 | 1984 | 31 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 1985 | 278 | 0.020 |
Why?
|
| Protein Binding | 1 | 2008 | 1456 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 2062 | 0.010 |
Why?
|
| Risk Factors | 2 | 2011 | 5417 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 3030 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2009 | 2601 | 0.010 |
Why?
|
| Methylmethacrylates | 2 | 1990 | 8 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 5976 | 0.010 |
Why?
|
| Surgical Instruments | 2 | 1989 | 57 | 0.010 |
Why?
|
| Eye | 2 | 1989 | 111 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1995 | 326 | 0.010 |
Why?
|
| Absorption | 1 | 1991 | 25 | 0.010 |
Why?
|
| Biological Availability | 1 | 1991 | 92 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1990 | 4213 | 0.010 |
Why?
|
| Freeze Drying | 1 | 1991 | 14 | 0.010 |
Why?
|
| Refractive Errors | 1 | 1990 | 4 | 0.010 |
Why?
|
| Organ Preservation | 1 | 1991 | 83 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1990 | 181 | 0.010 |
Why?
|
| Denervation | 1 | 1990 | 34 | 0.010 |
Why?
|
| R Factors | 1 | 1989 | 6 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 1990 | 83 | 0.010 |
Why?
|
| Conjugation, Genetic | 1 | 1989 | 22 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1991 | 172 | 0.010 |
Why?
|
| Vascular Patency | 1 | 1990 | 126 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1989 | 143 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1988 | 116 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1991 | 996 | 0.010 |
Why?
|
| Cell Survival | 1 | 1991 | 969 | 0.010 |
Why?
|
| Graft Survival | 1 | 1991 | 884 | 0.000 |
Why?
|
| Uvea | 1 | 1986 | 1 | 0.000 |
Why?
|
| Suppuration | 1 | 1986 | 9 | 0.000 |
Why?
|
| Conjunctivitis | 1 | 1986 | 6 | 0.000 |
Why?
|
| Sterilization | 1 | 1986 | 7 | 0.000 |
Why?
|
| Enterotoxins | 1 | 1986 | 19 | 0.000 |
Why?
|
| Drug Contamination | 1 | 1986 | 12 | 0.000 |
Why?
|
| Uveitis | 1 | 1986 | 29 | 0.000 |
Why?
|
| Esotropia | 1 | 1985 | 1 | 0.000 |
Why?
|
| Bacterial Toxins | 1 | 1986 | 111 | 0.000 |
Why?
|
| Uveal Diseases | 1 | 1985 | 3 | 0.000 |
Why?
|
| Pupil | 1 | 1985 | 18 | 0.000 |
Why?
|
| Methods | 1 | 1985 | 152 | 0.000 |
Why?
|
| Biodegradation, Environmental | 1 | 1985 | 17 | 0.000 |
Why?
|
| Fundus Oculi | 1 | 1984 | 33 | 0.000 |
Why?
|
| Glaucoma, Open-Angle | 1 | 1985 | 17 | 0.000 |
Why?
|
| Escherichia coli Proteins | 1 | 1986 | 179 | 0.000 |
Why?
|
| Melanocytes | 1 | 1984 | 56 | 0.000 |
Why?
|
| Radiation Injuries | 1 | 1986 | 155 | 0.000 |
Why?
|
| Intraocular Pressure | 1 | 1984 | 54 | 0.000 |
Why?
|
| Intraoperative Complications | 1 | 1985 | 185 | 0.000 |
Why?
|
| Nervous System Diseases | 1 | 1985 | 151 | 0.000 |
Why?
|
| Macular Edema | 1 | 1984 | 50 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1990 | 1195 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1985 | 268 | 0.000 |
Why?
|
| Inflammation | 1 | 1985 | 920 | 0.000 |
Why?
|